Back to search
FDAFDA · Food and drugs·Recall number Z-1773-2019

CardioCommand, Inc. Transesophageal Cardiac Pacing and Recording System, Model 7A, REF 0101 - Product Usage: Indications for Use: - Temporary left atrial pacing to treat bradycardia, hypotension or AV junctional rhythm - Acceleration of heart rate as an alternative to exercise or drugs during diagnostic cardiac studies such as echocardiography or radionuclide ventriculography. - Antitachycardia pacing for cardioversion of supraventricular tachycardia (SVT), including atrial flutter and re-entrant atrial or atrioventricular paroxysmal tachycardia. - Esophageal electrocardiography for differential diagnosis of complex atrial arrhythmia

Published June 19, 2019 · Recall initiated: May 10, 2019

Summary

FDA records medical device Class III recall Z-1773-2019, published June 19, 2019 and initiated May 10, 2019. Recalling firm: Cardiocommand Inc.; Status: Terminated; Reported quantity: 5 units; Lot: Serial Numbers: 8059, 8060, 8022, 8063, 8211. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Possible corrosion of the battery contact(s).

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Cardiocommand Inc.
Distributor
US Nationwide distribution in the states of CT, VW, OH, IL, DE.
Lot
Serial Numbers: 8059, 8060, 8022, 8063, 8211
Risk classification
Class III
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was CardioCommand, Inc. Transesophageal Cardiac Pacing and Recording System, Model 7A, REF 0101 - Product Usage: Indications for Use: - Temporary left atrial pacing to treat bradycardia, hypotension or AV junctional rhythm - Acceleration of heart rate as an alternative to exercise or drugs during diagnostic cardiac studies such as echocardiography or radionuclide ventriculography. - Antitachycardia pacing for cardioversion of supraventricular tachycardia (SVT), including atrial flutter and re-entrant atrial or atrioventricular paroxysmal tachycardia. - Esophageal electrocardiography for differential diagnosis of complex atrial arrhythmia recalled?

Yes. FDA published recall Z-1773-2019 on June 19, 2019. Reported hazard: Possible corrosion of the battery contact(s).

What should I do if I have this product?

Voluntary: Firm initiated · Letter